What is KMTS's cash & equivalents?

KMTS (KMTS) reported cash & equivalents of $291.32M in Q4 2025.

How has KMTS's cash & equivalents changed year-over-year?

KMTS's cash & equivalents increased by 436.0% year-over-year, from $54.35M to $291.32M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

KMTS KMTS Cash & Equivalents

Cash & Equivalents at other companies

AbbottABT

$6.8B+4.1%

Boston ScientificBSX

$850M+146%

MedtronicMDT

$1.95B-12.1%

iRhythm Holdings, Inc. IRTC

$248.5M-35.2%

Merit Medical SystemsMMSI

$488.08M+23.4%

HaemoneticsHAE

$245.44M-20.0%

Other financials

Income statement

See full

Revenue$24.6M+62.7%

Gross profit$12.9M+97.1%

Operating income-$34.8M-68.8%

Net income-$34.2M-58.8%

EPS (diluted)-$0.61+51.2%

Balance sheet

See full

Total debt$43.8M—

Total assets$379.3M—

Cash flow

See full

Operating cash flow-$18.4M-2.1%

CapEx$9.8M+141%

Free cash flow-$28.2M-27.7%

Valuation

See full

Market cap$1.29B+67.0%

Enterprise value$1.04B—

P/S15.4×—

Profitability

See full

Gross margin48.8%+15.1pp

Operating margin-171.5%+12.9pp

Net margin-173%+0.8pp

FCF margin-142.9%-25.3pp

Returns & leverage

See full

Current ratio7.3×—

Where this comes from

Reported directly by KMTS in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: KMTS’s 10-Q, filed March 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about KMTS's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is KMTS's cash & equivalents?: KMTS (KMTS) reported cash & equivalents of $291.32M in Q4 2025.
How has KMTS's cash & equivalents changed year-over-year?: KMTS's cash & equivalents increased by 436.0% year-over-year, from $54.35M to $291.32M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.